To pool the intellectual and scientific resources of member institutions to further research and discovery in cancer prevention and treatment strategies.
Since its inception in 2001, the American Eurasian Cancer Alliance (AECA) has implemented its vision of decreasing the burden of cancer in U.S. and Eurasian populations through strategic partnerships and programs that promote cancer research and enhance cancer control. Initially, AECA represented a unique partnership of scientists and clinicians from Russian Federation and the United States.
Based on the successes of AECA and growing interest from Europe and Asia, the scope and depth of the Alliance expanded to the Eurasian region and encompassed research, training, research to policy, and health diplomacy activities. Given the significance of this cooperation and the distinctiveness of programs implemented within Eurasia, AECA secured critical international support in order to facilitate programmatic success of cancer research and training initiatives for the mutual benefit of U.S. and local populations.
By 2014 AECA’s reach encompassed the following regions: Russian Federation, Central Asia (Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan), Central Europe (Ukraine, Moldova, Belarus), Baltics (Lithuania, Latvia, Estonia), and Caucasus (Armenia, Georgia, Azerbaijan).
The Alliance aims to pool intellectual and scientific resources to further research and discovery in cancer prevention and treatment strategies. AECA’s programs focus on three main areas:
Through continued engagement with high-level stakeholders, AECA facilitates the allocation of resources in alignment with these priorities for the mutual benefit of international communities. AECA, as one of the most established programs in Eurasian cancer research and training, builds successful cancer control programs with dependable partners in the region to ensure collaborative entities are committed to achieving a shared goal with common objectives.